Tagged as: Earnings

Q1 2021 Earnings Roundup: Biologics and Biosimilars Update

First Quarter Earnings Graphic

Below are some highlights from first quarter 2021 earnings reports recently released by biologics and biosimilars companies: At the end of last month, Biogen reported total quarterly revenues of $2,694 million, reflecting a 24% decrease versus the prior year’s first quarter. As reported by Biogen, this decrease reflects increased competition…

Read More